HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jakub Fichna Selected Research

Morphine (MS Contin)

1/2013The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in mice.
1/2012New neostigmine-based behavioral mouse model of abdominal pain.
9/2011The role of morphine in regulation of cancer cell growth.
11/2008Enzymatic degradation of endomorphins.
1/2007Endomorphin analogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jakub Fichna Research Topics

Disease

48Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023 - 09/2013
46Inflammation (Inflammations)
12/2023 - 01/2014
40Colitis
12/2023 - 06/2012
28Neoplasms (Cancer)
01/2024 - 12/2002
26Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
05/2023 - 08/2010
25Pain (Aches)
12/2023 - 02/2005
21Crohn Disease (Crohn's Disease)
12/2021 - 06/2014
21Abdominal Pain (Pain, Abdominal)
04/2020 - 01/2012
19Diarrhea
05/2023 - 07/2010
18Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 09/2014
14Ulcerative Colitis
08/2021 - 07/2014
13Constipation
03/2022 - 01/2015
11Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2022 - 01/2012
10Visceral Pain
04/2020 - 01/2012
9Colonic Neoplasms (Colon Cancer)
10/2022 - 07/2014
8Carcinogenesis
01/2024 - 01/2016
5Ulcer
12/2020 - 01/2016
5Breast Neoplasms (Breast Cancer)
10/2009 - 08/2004
4Colitis-Associated Neoplasms
01/2024 - 07/2014
4Asthma (Bronchial Asthma)
02/2022 - 01/2016
4Body Weight (Weight, Body)
11/2021 - 10/2019
4Pancreatitis
10/2021 - 06/2019
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 01/2021
3Disease Progression
10/2023 - 01/2021
3Neoplasm Metastasis (Metastasis)
10/2022 - 10/2009
3Obesity
01/2022 - 05/2018
3Multiple Sclerosis
01/2020 - 11/2012
2Sleep Initiation and Maintenance Disorders (Insomnia)
10/2023 - 10/2023
2Necrosis
10/2023 - 06/2019
2Adenocarcinoma
07/2023 - 06/2008
2Sleep Wake Disorders
03/2023 - 01/2021
2Cancer Pain
10/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

20Opioid Analgesics (Opioids)IBA
01/2024 - 08/2004
15Peroxidase (Myeloperoxidase)IBA
04/2023 - 06/2012
14Opioid Receptors (Opioid Receptor)IBA
01/2024 - 08/2004
11CytokinesIBA
03/2022 - 06/2014
10Dextran SulfateIBA
12/2023 - 01/2014
10Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2005
8mu Opioid Receptors (mu Opioid Receptor)IBA
06/2017 - 08/2004
7Dextrans (Dextran)FDA Link
04/2023 - 06/2012
7morphiceptinIBA
10/2020 - 12/2002
6Serotonin (5 Hydroxytryptamine)IBA
10/2023 - 10/2018
6G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2023 - 03/2017
6Biomarkers (Surrogate Marker)IBA
07/2023 - 02/2016
6Peptides (Polypeptides)IBA
11/2022 - 01/2009
6LigandsIBA
10/2022 - 08/2004
6Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2007
6Drinking WaterIBA
10/2020 - 10/2014
6CannabinoidsIBA
12/2019 - 01/2013
6Sulfonic AcidsIBA
01/2019 - 06/2012
5Castor Oil (Oil, Castor)IBA
01/2022 - 08/2014
5Fatty Acids (Saturated Fatty Acids)IBA
12/2021 - 01/2013
5AcidsIBA
12/2021 - 10/2015
5Nonesterified Fatty Acids (NEFA)IBA
11/2021 - 01/2020
5Trinitrobenzenesulfonic AcidIBA
08/2021 - 10/2014
5SilverIBA
07/2020 - 01/2015
5EnzymesIBA
01/2018 - 11/2012
5Morphine (MS Contin)FDA LinkGeneric
01/2013 - 01/2007
4Hormones (Hormone)IBA
01/2024 - 09/2013
4GoldIBA
12/2023 - 03/2021
4Messenger RNA (mRNA)IBA
07/2023 - 10/2009
4SodiumIBA
04/2023 - 01/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2023 - 06/2014
4EnkephalinsIBA
11/2022 - 10/2014
4PolyphenolsIBA
10/2022 - 06/2015
4SolutionsIBA
05/2021 - 01/2012
4Neprilysin (Neutral Endopeptidase)IBA
12/2020 - 12/2016
4Estrogens (Estrogen)FDA Link
12/2020 - 01/2018
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2020 - 06/2012
4CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2019 - 12/2014
4EndocannabinoidsIBA
11/2019 - 01/2013
4BerberineIBA
10/2019 - 01/2014
3AdiponectinIBA
01/2024 - 01/2021
3AdipokinesIBA
01/2024 - 03/2020
3Cisplatin (Platino)FDA LinkGeneric
04/2023 - 01/2019
3sialorphinIBA
11/2022 - 01/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2016
3Naloxone (Narcan)FDA LinkGeneric
11/2021 - 02/2014
3LipidsIBA
11/2021 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2016
3Estrogen ReceptorsIBA
12/2020 - 01/2019
3GTP-Binding Proteins (G-Protein)IBA
06/2019 - 03/2015
3MelatoninIBA
01/2018 - 02/2014
3N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA
05/2016 - 02/2014
3Melatonin Receptors (Melatonin Receptor)IBA
05/2016 - 02/2014
3Narcotic Antagonists (Opioid Antagonists)IBA
02/2016 - 01/2009
3Opiate AlkaloidsIBA
06/2010 - 01/2007
2AdipoRonIBA
01/2024 - 05/2021
2ORALIT (ORS)IBA
01/2024 - 11/2021
25-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
05/2023 - 01/2018
2Neurotransmitter Agents (Neurotransmitter)IBA
05/2023 - 09/2013
2AntioxidantsIBA
04/2023 - 07/2014
2Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2023 - 01/2021
2Vitamin A (Retinol)FDA LinkGeneric
01/2023 - 11/2017
2Antineoplastic Agents (Antineoplastics)IBA
10/2022 - 01/2019
2Tight Junction ProteinsIBA
03/2022 - 01/2017

Therapy/Procedure

40Therapeutics
12/2023 - 02/2010
5Drug Therapy (Chemotherapy)
11/2022 - 06/2015
3Biological Therapy
01/2020 - 06/2014
2Injections
12/2023 - 03/2014